Paclitaxel

Docetaxel head to head

Docetaxel head to head

By Anna Lewcock

Two manufacturers launched their docetaxel products at CPhI last
week, each trying to stake their claim in the market in
anticipation of patent expiries on Sanofi-Aventis' Taxotere
(docetaxel) towards the end of the year.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All